Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 383 citations, 2019 year and hybrid oa status.
383
Citations
2019
Year
hybrid
OA Status